Nkarta (NKTX) Other Non Operating Income (2019 - 2026)
Nkarta (NKTX) posted quarterly Other Non Operating Income of $206000.0 for Q1 2026, little changed year-over-year from $205000.0 in Q1 2025, and down 19.53% quarter-over-quarter from $256000.0 in Q4 2025.
Nkarta (NKTX) Other Non Operating Income (2019 - 2026) Analysis & Trends
Nkarta's Other Non Operating Income history runs 8 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income changed 0.49% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at $2.4 million (up 723.13% YoY), while the FY2025 annual figure was $2.4 million, up 2680.46% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $206000.0, down from $256000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.7 million in Q3 2025, with the low at -$489000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is $17000.0 (2022), against an average of $134352.9.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income sank 24350.0% in 2022, then jumped 57400.0% in 2025.
- Nkarta's Other Non Operating Income stood at -$489000.0 in 2022, then jumped by 94.89% to -$25000.0 in 2023, then jumped by 476.0% to $94000.0 in 2024, then jumped by 172.34% to $256000.0 in 2025, then declined by 19.53% to $206000.0 in 2026.
- Business Quant data shows NKTX's Other Non Operating Income at $206000.0 in Q1 2026, $256000.0 in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | -489,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -6,000.00 |